XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.1

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis

Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows:

									Quoted Prices in Active Markets for Identical Assets						Significant Other Observable Inputs						Little or No Market Activity Inputs
As of March 31, 2021 (In thousands)			Total						(Level 1)						(Level 2)						(Level 3)
Assets
Cash equivalents:
Corporate debt securities			$	2,215					$	—					$	2,215					$	—
Money market funds and other			723,040						723,040						—						—
U.S. Treasury securities			1,000						—						1,000						—
Marketable securities:
Corporate debt securities			441,852						—						441,852						—
Municipal securities			68,803						—						68,803						—
Sovereign securities			3,057						—						3,057						—
U.S. Government agency securities			147,673						147,673						—						—
U.S. Treasury securities			238,750						185,745						53,005						—
Total cash equivalents and marketable securities(1)			1,626,390						1,056,458						569,932						—
Other current assets:
Derivative assets			11,718						—						11,718						—
Other non-current assets:
Executive Deferred Savings Plan			253,849						194,917						58,932						—
Total financial assets(1)			$	1,891,957					$	1,251,375					$	640,582					$	—
Liabilities
Derivative liabilities			$	(3,450)					$	—					$	(3,450)					$	—
Deferred payments			(4,475)						—						—						(4,475)
Contingent consideration payable			(7,394)						—						—						(7,394)
Total financial liabilities			$	(15,319)					$	—					$	(3,450)					$	(11,869)

________________

(1) Excludes cash of $654.5 million held in operating accounts and time deposits of $161.8 million (of which $71.4 million were cash equivalents) as of March 31, 2021.

Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows:  

									Quoted Prices in Active Markets for Identical Assets						Significant Other Observable Inputs						Little or No Market Activity Inputs
As of June 30, 2020 (In thousands)			Total						(Level 1)						(Level 2)						(Level 3)
Assets
Cash equivalents:
Money market funds and other			$	694,950					$	694,950					$	—					$	—
Marketable securities:
Corporate debt securities			381,957						—						381,957						—
Municipal securities			29,110						—						29,110						—
Sovereign securities			2,017						—						2,017						—
U.S. Government agency securities			106,336						106,336						—						—
U.S. Treasury securities			181,193						151,210						29,983						—
Total cash equivalents and marketable securities(1)			1,395,563						952,496						443,067						—
Other current assets:
Derivative assets			2,077						—						2,077						—
Other non-current assets:
Executive Deferred Savings Plan			213,487						166,000						47,487						—
Total financial assets(1)			$	1,611,127					$	1,118,496					$	492,631					$	—
Liabilities
Derivative liabilities			$	(1,410)					$	—					$	(1,410)					$	—
Deferred payments			(6,750)						—						—						(6,750)
Contingent consideration payable			(15,513)						—						—						(15,513)
Total financial liabilities			$	(23,673)					$	—					$	(1,410)					$	(22,263)

________________

(1) Excludes cash of $460.8 million held in operating accounts and time deposits of $124.2 million (of which $78.7 million were cash equivalents) as of June 30, 2020.

X

- References

No definition available.

+ Details

Name:	us-gaap_FairValueDisclosuresAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration